In Vivo: Touchlight To Disrupt DNA Market with Synthetic Manufacturing

Karen Fallen, CEO of Touchlight DNA Services, talks to In Vivo’s William Masters about Touchlight’s financing, facility expansion, dbDNA™ technology and CDMO offer.

Read more